|Dr. Roberto Gramignoli
Roberto Gramignoli, Assistant Professor, Dept. Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
|Dr. Roberto Gramignolipresently working as an assistant professor at Karolinska Institute, Sweden.He has won many awards in the field of medicine some of which inclde: Travel Grants (ASBMT-ISCT, 2015; Cell Transplant Society Young Investigator, 2013; European Science Foundation, 2012; Progetto Cariplo, 2011 & 2013; Marie Curie Educational Program, 2006) Fellowship from American national PKU Alliance, USA, 2010 & 2011 etc. Some of his publications include: Gramignoli R. Therapeutic Use of Human Amnion-Derived Products: Cell-Based Therapy for Liver Disease. Curr Pathobiol Rep 2016; 4:157?167 ? Gramignoli R, Srinivasan RC, Kannisto K, Strom SC. Isolation of Human Amnion Epithelial Cells according to current Good Manufacturing Procedures, GMP. Curr Protoc Stem Cell Biol, 2016; 37:1E.10.1-1E.10.13 Gramignoli R, Strom SC. HLA-G Expression in Human Amnion Epithelial Cells in Treatment for Liver Diseases. Hum Immunol, 2016; 77(9):734-9 ? Giebel NL, Shadley JD, McCarver DG, Dorko K, Gramignoli R, Strom SC, Yan K, Simpson PM, Hines RN. Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. Drug Metab Dispos 2016; 44(7):1027-37|
|Therapy for Liver Disease, Liver Diseases|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : April 24, 2019